Company
Jasper Therapeutics, Inc. (JSPR)
Standardized SEC financial data for Jasper Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001788028 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-1000.0%
Free cash flow
-$77.2M
Current ratio
2.63×
EPS (diluted)
$-3.95
Income statement
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cost of revenue | — | — | — | — | $34.3M | $41.6M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.2M | $85.0M | $38.7M | $87.3M | $72.1M | $29.1M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$18.3M | -$33.7M | -$45.9M | -$52.1M | -$62.6M | -$77.2M |
| Investing cash flow |
Get JSPR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/JSPR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/JSPR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"